Claudia C. Sombroek

Claudia C. Sombroek

Auto-generated profile, based on publicly available information

Claudia C. Sombroek

Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Cell Reports Medicine
Verified
Journal Article
Open access
KDKarin Dijkman
Karin Dijkman
NANacho Aguilo
Nacho Aguilo
CBCharelle Boot
Charelle Boot
SHSam O. Hofman
Sam O. Hofman
CSClaudia C. Sombroek
Claudia C. Sombroek
FVFrank Verreck
Frank Verreck
To fight tuberculosis, better vaccination strategies are needed. Live attenuated Mycobacterium tuberculosis-derived vaccine, MTBVAC, is a promising candidate in the pipeline, proven to be safe and immunogenic in humans so far. Independent studies have shown that pulmonary mucosal delivery of Bacillus Calmette-Guérin (BCG), the only tuberculosis (TB) vaccine available today, confers superior protection over standard intradermal immunization. Here we demonstrate that mucosal MTBVAC is well tolerated, eliciting polyfunctional T helper type 17 cells, interleukin-10, and immunoglobulins in the airway and yielding a broader antigenic profile than BCG in rhesus macaques. Beyond our previous work, we show that local immunoglobulins, induced by MTBVAC and BCG, bind to M. tuberculosis and enhance pathogen uptake. Furthermore, after pulmonary vaccination, but not M. tuberculosis infection, local T cells expressed high levels of mucosal homing and tissue residency markers. Our data show that pulmonary MTBVAC administration has the potential to enhance its efficacy and justifies further exploration of mucosal vaccination strategies in preclinical efficacy studies.

18 March 2014 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
JLJelle J Lindenberg
Jelle J Lindenberg
RVRieneke Van De Ven
Rieneke Van De Ven
DODinja Oosterhoff
Dinja Oosterhoff
CSClaudia C Sombroek
Claudia C Sombroek
SLSinéad M Lougheed
Sinéad M Lougheed
TGTanja De Gruijl
Tanja De Gruijl
Autologous tumor cell-based vaccines provide a wide range of tumor antigens and personalized neo-epitopes based on individual tumors’ unique antigenic mutanome signatures. However, tumor-derived factors may hamper in situ maturation of dendritic cells (DC) and thus interfere with the generation of effective anti-tumor immunity. As the skin is a preferred site for tumor vaccine delivery, we investigated the influence of primary colon carcinoma-derived soluble factors on the maturation state of migrating DC in a human skin explant model. Primary tumor-derived supernatants (TDSN) enhanced the phenotypic maturation state of skin-emigrated DC, resulting in an increased T-cell stimulatory ability in an allogeneic mixed leukocyte response. In case of monocyte-derived DC a similar TDSN-induced maturation induction was found to entirely depend on cyclooxygenase (COX)-regulated prostaglandins. In contrast, the increase in skin-emigrated DC maturation was completely prostaglandin-independent, as evidenced by the ina...